Compounds > delta sleep-inducing peptide

Page last updated: 2024-08-25

delta sleep-inducing peptide and Drug Withdrawal Symptoms

delta sleep-inducing peptide has been researched along with Drug Withdrawal Symptoms in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (42.86)	18.7374
1990's	3 (42.86)	18.2507
2000's	1 (14.29)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dick, P; Grandjean, ME; Tissot, R	1
Aeppli, L; Haefely, W; Polc, P; Scherschlicht, R	1
Costa, C; Dick, P; Fayolle, K; Grandjean, ME; Khoshbeen, A; Tissot, R	1
Rothenhaeusler, HB; Soyka, M	1
Backmund, M; Meyer, K; Rothenhaeusler, HB; Soyka, M	1
Heimberg, D; Hobi, V; Hruz, P; Müller-Spahn, F; Scheffler, K; Schönenberger, GA; Seifritz, E; Zechner, S	1
Maĭskiĭ, AI; Salimov, RM; Viglinskaia, IV	1

Trials

1 trial(s) available for delta sleep-inducing peptide and Drug Withdrawal Symptoms

Article	Year
Opioid detoxification with delta sleep-inducing peptide: results of an open clinical trial. Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:3 Topics: Adult; Delta Sleep-Inducing Peptide; Heroin; Heroin Dependence; Humans; Inactivation, Metabolic; Self-Assessment; Substance Withdrawal Syndrome	1998

Other Studies

6 other study(ies) available for delta sleep-inducing peptide and Drug Withdrawal Symptoms

Article	Year
Successful treatment of withdrawal symptoms with delta sleep-inducing peptide, a neuropeptide with potential agonistic activity on opiate receptors. Neuropsychobiology, 1983, Volume: 10, Issue:4 Topics: Adult; Delta Sleep-Inducing Peptide; Drug Evaluation; Ethanol; Female; Humans; Male; Middle Aged; Narcotics; Nerve Tissue Proteins; Oligopeptides; Receptors, Opioid; Substance Withdrawal Syndrome	1983
Some pharmacological effects of delta-sleep-inducing peptide (DSIP). European neurology, 1984, Volume: 23, Issue:5 Topics: Animals; Cats; Delta Sleep-Inducing Peptide; Humans; Injections, Intravenous; Injections, Subcutaneous; Male; Mice; Morphine; Naloxone; Oligopeptides; Rabbits; Sleep; Sleep Initiation and Maintenance Disorders; Stress, Psychological; Substance Withdrawal Syndrome	1984
DSIP in the treatment of withdrawal syndromes from alcohol and opiates. European neurology, 1984, Volume: 23, Issue:5 Topics: Adult; Delta Sleep-Inducing Peptide; Ethanol; Female; Heroin; Humans; Injections, Intravenous; Male; Methadone; Middle Aged; Narcotics; Oligopeptides; Pentazocine; Substance Withdrawal Syndrome	1984
Delta sleep-inducing peptide in opioid detoxification. The American journal of psychiatry, 1997, Volume: 154, Issue:5 Topics: Adult; Delta Sleep-Inducing Peptide; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Opioid-Related Disorders; Substance Withdrawal Syndrome	1997
Intranasal administration of delta sleep-inducing peptide increases P300. Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:6 Topics: Administration, Intranasal; Adult; Cross-Over Studies; Delta Sleep-Inducing Peptide; Double-Blind Method; Event-Related Potentials, P300; Humans; Injections, Intravenous; Male; Opioid-Related Disorders; Substance Withdrawal Syndrome	2001
[Effects of delta sleep-inducing peptide on electrophysiological parameters of sleep during alcohol withdrawal in rats]. Biulleten' eksperimental'noi biologii i meditsiny, 1990, Volume: 110, Issue:9 Topics: Animals; Delta Sleep-Inducing Peptide; Ethanol; Male; Rats; Sleep; Sleep, REM; Substance Withdrawal Syndrome; Time Factors	1990